Guilt 'won't ever go away' for families caught up in valproate scandal
BBC"Even though I know it's not my fault, the guilt continues and I don't think it will ever go away."
Emma Friedmann's son Andrew is one of an estimated 20,000 children in UK believed to have been harmed by the epilepsy drug sodium valproate since it was first used to treat the condition in the 1970s.
Babies exposed to valproate medicines in the womb have a 10% chance of developing physical abnormalities and 40% chance of developing cognitive problems, such as learning disabilities and autism.
The 28-year-old, from Leicester, has severe autism, learning disabilities and will never live independently.
Emma said she was not fully informed of the risks of taking the drug while she was pregnant with Andrew in the late 1990s.
She spoke to the BBC following the broadcast of new documentary Mums vs Big Pharma, which examined the scandal.
Emma, 54, said her son loved performing and singing as well as planning journeys out with her and taking part in quizzes.
However, he struggles to express himself, has poor co-ordination and does not understand danger.
"He will never achieve full mental capacity and he needs 24/7 support," Emma said.
"What happens when I die? Where will he live? Who will manage his wellbeing, finances, education, employment and recreation?
"Who will make sure he has a safe and happy life when I am no longer able to provide for him?"
Emma FriedmannSodium valproate was first licensed to treat epilepsy in the UK in 1972. At that time, it was known to be harmful to a developing fetus in animals, the NHS said.
Scientific papers as early as the 1980s suggested valproate medicines were dangerous to developing human babies, before further evidence emerged during the 1990s.
Warnings were passed to doctors about an association with development delay in 2003, verbal IQ in 2005, and reports of autism spectrum disorders in 2010.
As a result, warnings about the harm the drug could cause to an unborn baby were added to the outside of valproate pill packets in 2016.
The government-commissioned 2020 Cumberlege Report heard from families who "did not receive information about the risks of treatment with sodium valproate during pregnancy", which "prevented women from making informed choices about their treatment and family planning options", leading to "lifelong impacts on their families".
The latest guidance from the Medicines and Healthcare products Regulatory Agency (MHRA) says valproate must not be prescribed to any woman or girl able to have children unless the conditions of the pregnancy prevention programme (PPP) are followed.
'No excuse'
Speaking about the documentary, which also told the stories of two other mothers who were affected by the scandal, Emma said: "These women have played an essential role but are part of a collaborative effort that shows the strength of women when we unite around a cause.
"The documentary told my story from being a girl with epilepsy to being a mother with a child with disabilities and then getting involved with campaigning.
"My priority now is getting adequate services for son - and the services are inadequate.
"We deal with this when our children are at school and we are still dealing with this when our children are adults."
Emma has been a member of the FACSaware movement - short for fetal anti-convulsant syndrome - and acted as an expert witness for several all-party parliamentary groups, the MHRA and the 2020 Cumberlege review.
"We want to prevent this from happening to other people and improve the lives of those who it happened to," Emma added.
"There's no excuse for them not issuing compensation. [The] Conservatives and Labour have both agreed it's successive government failures."
A further report in 2024 by Patient Safety Commissioner Dr Henrietta Hughes said the "case for redress is clear" and it must "span financial and non-financial aspects to make the lives of those harmed better".
The Department of Health and Social Care (DHSC) said a decision on financial redress had not yet been made, while manufacturer Sanofi said it understood "the concerns of persons affected".
Emma FriedmannMeanwhile, Emma is calling for changes to consumer protection law and product liability law - and she does not feel taxpayers should have to foot the bill for compensation.
Instead she would like to see a tax on the pharmaceutical industry to push it to improve the safety of its products - potentially working in a similar fashion to how the "sugar tax" forced soft drinks manufacturers to reduce the amount of sugar in their drinks.
In 2010, families in England and Wales had to abandon a court case against Sanofi when their legal aid was withdrawn three weeks before the case was due to begin.
"The pharmaceutical company needs to be taxed on the harm their products have caused," Emma said.
"As far as improving the system for British citizens, the law needs to be changed or we are going to continue to see this issue happen until the law is changed.
"They cannot be held to account in UK law."
Rebekah Smith, chief executive of Epilepsy Action, said compensation for families was something that "really needs to happen".
"It has been a history of a number of women not being given the appropriate information at the appropriate time," she said.
"For many parents the biggest fear is what will happen to their children when they are no longer around or able to care for them.
"No amount of money can undo the harm caused, but these families deserve the reassurance that their children will have the care, support and financial security they need for the future.
"That's why redress matters so much."
Listen to BBC Radio Leicester on Sounds and follow BBC Leicester on Facebook, on X, or on Instagram. Send your story ideas to eastmidsnews@bbc.co.uk or via WhatsApp on 0808 100 2210.
